Situations
One card per real event, not per article. Where several outlets covered the same development, Wire collapses that reporting into a single situation.
60 situations under Opportunities, most recently developed first.
Tesla to launch Cybercab in Austin this month
58 reports · 37 domains · 19× the usual spread
First seen 17 Aug 2026 · Updated 5 Sept 2026
Analysis developing
Novartis Lp(a) drug fails closely watched ph. 3 trial
2 reports · 2 domains
First seen 5 Sept 2026 · Updated 5 Sept 2026
Analysis developing
Tesla Readies August Launch Of Cybercab, Its Robotaxi Without A Steering Wheel
54 reports · 45 domains · 23× the usual spread
First seen 17 Aug 2026 · Updated 5 Sept 2026
Analysis developing
FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
59 reports · 51 domains · 26× the usual spread
First seen 26 Aug 2026 · Updated 5 Sept 2026
Analysis developing
FDA Approves Ustekinumab Injection for Pediatric Ulcerative Colitis, Expanding IBD Options ...
2 reports · 2 domains
First seen 31 Aug 2026 · Updated 5 Sept 2026
Analysis developing
CRISPR Therapeutics gains FDA approval for CASG...
2 reports · 2 domains
First seen 5 Sept 2026 · Updated 5 Sept 2026
Analysis developing
Tesla set to launch driverless Cybercab, reports say
5 reports · 5 domains · 2.5× the usual spread
First seen 18 Aug 2026 · Updated 5 Sept 2026
Analysis developing
FDA approves Ionis' antisense drug as first targeted therapy for Alexander disease
12 reports · 12 domains · 6× the usual spread
First seen 3 Sept 2026 · Updated 5 Sept 2026
Analysis developing
AstraZeneca's Breast Cancer Pill Gets Approval From the FDA
5 reports · 5 domains · 2.5× the usual spread
First seen 4 Sept 2026 · Updated 5 Sept 2026
Analysis developing
FDA Grants Accelerated Approval to a New Breast Cancer Treatment
8 reports · 7 domains · 3.5× the usual spread
First seen 4 Sept 2026 · Updated 5 Sept 2026
Analysis developing
CMS Prevents $1.6 Billion in Fraudulent Medicare Laboratory Payments
2 reports · 2 domains
First seen 28 Aug 2026 · Updated 5 Sept 2026
Analysis developing
Tesla Shifts Robotaxi Strategy From Model Y to Cybercab as JPMorgan Highlights Purpose ...
5 reports · 5 domains · 2.5× the usual spread
First seen 21 Aug 2026 · Updated 4 Sept 2026
Analysis developing
OpenAI hails 'new era of artificial general intelligence' with Astra model release
7 reports · 7 domains · 3.5× the usual spread
First seen 3 Sept 2026 · Updated 4 Sept 2026
Analysis developing
Autonomous Vehicles & Group Transit: Why Human Drivers Remain Essential for 2026 Boom
2 reports · 2 domains
First seen 4 Sept 2026 · Updated 4 Sept 2026
Analysis developing
Trafera Acquires Morris Electronics, Further Strengthening its State and Local Government ...
2 reports · 2 domains
First seen 2 Sept 2026 · Updated 4 Sept 2026
Analysis developing
PATH Q2 Deep Dive: AI Adoption, Platform Consolidation, and Execution Challenges Shape Outlook
2 reports · 2 domains
First seen 4 Sept 2026 · Updated 4 Sept 2026
Analysis developing
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis
4 reports · 4 domains · 2× the usual spread
First seen 28 Aug 2026 · Updated 4 Sept 2026
Analysis developing
Novocure hit by cyberattack exposing patient data
3 reports · 3 domains
First seen 1 Sept 2026 · Updated 4 Sept 2026
Analysis developing
Medibyt Receives FDA 510(k) Clearance for CPETWise, Advancing Cardiopulmonary ...
5 reports · 5 domains · 2.5× the usual spread
First seen 1 Sept 2026 · Updated 4 Sept 2026
Analysis developing
Cloudflare Partners with OpenAI Daybreak Models to Redefine Vulnerability Management ...
2 reports · 2 domains
First seen 3 Sept 2026 · Updated 4 Sept 2026
Analysis developing
GLP-1 use in US kids under-12 soars
2 reports · 2 domains
First seen 4 Sept 2026 · Updated 4 Sept 2026
Analysis developing
FDA Allows First Gene Therapy Clinical Trial for Ultra-Rare Pediatric Neurodegenerative Disease
2 reports · 2 domains
First seen 3 Sept 2026 · Updated 4 Sept 2026
Analysis developing
FDA clears C2N Diagnostics' PrecivityAD2 blood test for Alzheimer's diagnosis in adults aged 40+
11 reports · 11 domains · 5.5× the usual spread
First seen 20 Aug 2026 · Updated 4 Sept 2026
Analysis developing
Uber and Wayve launch their first robotxi services in London.
15 reports · 15 domains · 7.5× the usual spread
First seen 3 Sept 2026 · Updated 4 Sept 2026
Analysis developing
Abu Dhabi AI institute releases fully open-source models with training data, code
8 reports · 7 domains · 3.5× the usual spread
First seen 3 Sept 2026 · Updated 4 Sept 2026
Analysis developing
Decoding nature: How AI is driving Saudi Arabia's rewilding revolution
2 reports · 2 domains
First seen 3 Sept 2026 · Updated 4 Sept 2026
Analysis developing
21000 Exchange Servers Exposed to Public PoC Exploit After Pwn2Own $200K Chain Demo
2 reports · 2 domains
First seen 1 Sept 2026 · Updated 4 Sept 2026
Analysis developing
Heartvue.ai and Innolitics Achieve FDA 510(k) Clearance for Heartvue.Proton, an AI ...
3 reports · 3 domains
First seen 2 Sept 2026 · Updated 4 Sept 2026
Analysis developing
SK Telecom, Kakao, KT Selected for 'AI for Everyone' Project
2 reports · 2 domains
First seen 28 Aug 2026 · Updated 4 Sept 2026
Analysis developing
Faraday Future expands robotics push in Middle East, set to launch new products
2 reports · 2 domains
First seen 30 Aug 2026 · Updated 4 Sept 2026
Analysis developing
Tenable Uses OpenAI GPT Cyber Models to Help Defenders Inspect Community-Built AI ...
2 reports · 2 domains
First seen 3 Sept 2026 · Updated 4 Sept 2026
Analysis developing
Solvay to more than double Taiwan chip peroxide capacity, targets tripling electronic-grade business
4 reports · 4 domains · 2× the usual spread
First seen 3 Sept 2026 · Updated 3 Sept 2026
Analysis developing
Should Investors Buy RDW as Defense Growth Meets a Premium Valuation?
2 reports · 2 domains
First seen 3 Sept 2026 · Updated 3 Sept 2026
Analysis developing
Quantinuum Signs Non-binding MOU with Aramco to Explore Synergies Leveraging ...
4 reports · 4 domains · 2× the usual spread
First seen 3 Sept 2026 · Updated 3 Sept 2026
Analysis developing
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing ...
2 reports · 2 domains
First seen 3 Sept 2026 · Updated 3 Sept 2026
Analysis developing
Agentic AI Skilling: NIELIT and Intel Launch National Initiative
4 reports · 4 domains · 2× the usual spread
First seen 3 Sept 2026 · Updated 3 Sept 2026
Analysis developing
Palo Alto Networks Acquires Console to Agentify Security
5 reports · 5 domains · 2.5× the usual spread
First seen 1 Sept 2026 · Updated 3 Sept 2026
Analysis developing
Former Minister Mikhail Fedorov announced the launch of a new Defense Tech company ...
8 reports · 8 domains · 4× the usual spread
First seen 1 Sept 2026 · Updated 3 Sept 2026
Analysis developing
FDA clears new blood-based biomarker test that targets tau
3 reports · 3 domains
First seen 25 Aug 2026 · Updated 3 Sept 2026
Analysis developing
Google launches Gemini 3.7 Flash AI model for coding
9 reports · 9 domains · 4.5× the usual spread
First seen 13 Aug 2026 · Updated 3 Sept 2026
Analysis developing
Google Launches Gemini 3.8 Flash: Performance Nears Top Model Claude Opus 5 ...
5 reports · 5 domains · 2.5× the usual spread
First seen 2 Sept 2026 · Updated 3 Sept 2026
Analysis developing
China achieves 98% transmission efficiency in single quantum router breakthrough
2 reports · 2 domains
First seen 3 Sept 2026 · Updated 3 Sept 2026
Analysis developing
Serbia begins serial production of humanoid robots with Chinese firm
2 reports · 2 domains
First seen 30 Aug 2026 · Updated 3 Sept 2026
Analysis developing
Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome
2 reports · 2 domains
First seen 3 Sept 2026 · Updated 3 Sept 2026
Analysis developing
Enovis to acquire eCential Robotics for €155 million, plans to bring surgical robot to market
3 reports · 3 domains
First seen 1 Sept 2026 · Updated 3 Sept 2026
Analysis developing
ai& and Tenstorrent Launch JapanFold, Bringing Open-Source, Sovereign Drug Discovery to Japan
2 reports · 2 domains
First seen 3 Sept 2026 · Updated 3 Sept 2026
Analysis developing
FDA Expands Dolutegravir Approval to Infants With HIV-1 Weighing at Least 2 kg
4 reports · 4 domains · 2× the usual spread
First seen 26 Aug 2026 · Updated 3 Sept 2026
Analysis developing
Teva moves closer to a drug for celiac disease with positive Phase 2 results
3 reports · 3 domains
First seen 2 Sept 2026 · Updated 3 Sept 2026
Analysis developing
AI Model Evaluator METR Hit by Credential Theft, Probing
2 reports · 2 domains
First seen 2 Sept 2026 · Updated 3 Sept 2026
Analysis developing
Pancreatic cancer drug approved by FDA is "exceptional moment," Boston researcher says
3 reports · 3 domains
First seen 27 Aug 2026 · Updated 3 Sept 2026
Analysis developing
Scholar Rock: FDA Grants Fast Track And Orphan Drug Designations To Apitegromab
2 reports · 2 domains
First seen 2 Sept 2026 · Updated 3 Sept 2026
Analysis developing
Tencent releases open-source Hy4 preview model
2 reports · 2 domains
First seen 29 Aug 2026 · Updated 3 Sept 2026
Analysis developing
Aesto Health data breach hits 9.5 million patients: What to know
3 reports · 3 domains
First seen 1 Sept 2026 · Updated 2 Sept 2026
Analysis developing
uniQure seeks US approval for Huntington's gene therapy after FDA reversal
3 reports · 3 domains
First seen 2 Sept 2026 · Updated 2 Sept 2026
Analysis developing
From Diagnoses to Treatments, Why Americans Use AI Chatbots for Health
2 reports · 2 domains
First seen 25 Aug 2026 · Updated 2 Sept 2026
Analysis developing
FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia
11 reports · 10 domains · 5× the usual spread
First seen 31 Aug 2026 · Updated 2 Sept 2026
Analysis developing
Samsung showcases chip 3D architecture strategy at SEMICON Taiwan
2 reports · 2 domains
First seen 1 Sept 2026 · Updated 2 Sept 2026
Analysis developing
Charles IT Expands AI and Automation Capabilities Through Acquisition of Descent
2 reports · 2 domains
First seen 2 Sept 2026 · Updated 2 Sept 2026
Analysis developing
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
11 reports · 10 domains · 5× the usual spread
First seen 28 Aug 2026 · Updated 2 Sept 2026
Analysis developing
FDA Approves Ziihera Regimens in First-Line HER2+ Advanced GEA
14 reports · 10 domains · 5× the usual spread
First seen 25 Aug 2026 · Updated 2 Sept 2026
Analysis developing